Research institute
Putting together research for publication can be a challenging and time-consuming process, heightened even further because of the current COVID-19 situation, during which non-essential labs have been hibernated and many researchers are now working separately and remotely, instead of collaborating within the same space.
Could antibodies found in the blood of llamas, the doe-eyed South American pack animal, hold a key to developing a vaccine for COVID-19? A team of researchers from Belgium believes so.
According to the research, published in Nature Cell Biology, targeted doses of doxorubicin could potentially inhibit the interaction between two molecular pathways that work together to encourage tumor growth.
The Regenstrief Institute and Indiana University are launching a survey to conduct research about COVID-19 symptoms.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
It will test the use of tradipitant for neurogenic inflammation of the lung secondary to SARS-CoV-2 infection.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 15, 2020.
The protein, called a nicotinic receptor, has been a challenge to study since it sits in the cell’s membrane.
The investigators assayed the levels and analyzed the expression patterns of more than 3,000 proteins in brain and cerebrospinal fluid samples collected at centers across the U.S.
The goal is to connect trial sites, sponsors and clinical research organizations to speed COVID-19 clinical trials for vaccines, drugs and diagnostics.
PRESS RELEASES